<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01512134</url>
  </required_header>
  <id_info>
    <org_study_id>2011H0329</org_study_id>
    <nct_id>NCT01512134</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation for the Treatment of Obesity</brief_title>
  <official_title>Deep Brain Stimulation For Morbid, Treatment-Refractory, Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ali Rezai, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical study is to investigate the safety and efficacy of deep brain
      stimulation (DBS) as a treatment option for obesity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this clinical study is to investigate the safety and efficacy of deep brain
      stimulation (DBS) as a treatment option in the management of severe, treatment refractory,
      morbid obesity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of excess weight loss</measure>
    <time_frame>2 years</time_frame>
    <description>The primary outcome measure at the conclusion of the study will be percent of excess weight loss (EWL).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>DBS Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients enrolled will undergo DBS implantation in the targeted region to assess the safety of the procedure and the efficacy through weight loss.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation Device</intervention_name>
    <description>Deep brain stimulation surgery</description>
    <arm_group_label>DBS Surgery</arm_group_label>
    <other_name>Reclaim</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 24 months post Roux-en-Y gastric bypass surgery without evidence of a
             sustained improvement in BMI after gastric bypass surgery for at least 6 months.

          -  Participant is willing to comply with all follow-up evaluations at the specified times

          -  Participant is able to provide informed consent

          -  Fluent in English

        Exclusion Criteria:

          -  Medical contraindications for general anesthesia, craniotomy, or DBS surgery

          -  Evidence of neurological disorders, e.g., multiple sclerosis, Parkinson's disease and
             ischemic stroke, or severe brain atrophy or the presence of subdural hygromas or
             subdural hematomas.

          -  Severe cardiovascular, pulmonary, renal, liver, hematological disease, severe
             coagulopathy, acute infectious process
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Rezai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2012</study_first_submitted>
  <study_first_submitted_qc>January 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2012</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Ali Rezai, MD</investigator_full_name>
    <investigator_title>Professor of Neurological Surgery</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>DBS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

